Gene · 4605
Papers2,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Helicobacter pylori infection induces STAT3/MYBL2/NF-κB axis to promote gastric cancer progression. | Tissue Cell | 2025 | 40554138 | PubTator, text mining | PubMed |
| Hypoxic HPV-Positive Cancer Cells Are Particularly Sensitive to the Pro-Senescent Effects of B-MYB Repression Due to the Lack of Compensatory A-MYB Induction. | J Med Virol | 2025 | 40444458 | PubTator, text mining | PubMed |
| MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation. | Front Oncol | 2025 | 40432915 | PubTator, text mining | PubMed |
| Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes. | Breast Cancer Res Treat | 2025 | 40425927 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
| Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1/2 axis and does not require activation of DREAM. | Cell Death Dis | 2025 | 40319068 | PubTator, text mining | PubMed |
| Comprehensive analysis of transcriptome and microbiome in colorectal cancer with synchronous polyp patients. | Front Cell Infect Microbiol | 2025 | 40313460 | PubTator, text mining | PubMed |
| EMC2 promotes breast cancer progression and enhances sensitivity to PDK1/AKT inhibition by deubiquitinating ENO1. | Int J Biol Sci | 2025 | 40303285 | PubTator, text mining | PubMed |
| Dysregulation of MYBL2 impairs extravillous trophoblast lineage development and function, contributing to recurrent spontaneous abortion. | Proc Natl Acad Sci U S A | 2025 | 40294258 | PubTator, text mining | PubMed |
| Identification of the oncogenic role of centromere protein M in non-small cell lung cancer via CDC20/MYBL2/Wnt signaling pathways. | J Mol Histol | 2025 | 40285932 | PubTator, text mining | PubMed |
| A gene signature associated with cellular senescence serves as an important prognostic indicator in hepatocellular carcinoma. | Transl Cancer Res | 2025 | 40224975 | PubTator, text mining | PubMed |
| Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. | Pharmaceuticals (Basel) | 2025 | 40143207 | PubTator, text mining | PubMed |
| Retraction: MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis. | Oncol Res | 2025 | 40109855 | PubTator, text mining | PubMed |
| MYBL2 promotes cell proliferation and inhibits cell apoptosis via PI3K/AKT and BCL2/BAX/Cleaved-caspase-3 signaling pathway in gastric cancer cells. | Sci Rep | 2025 | 40097530 | PubTator, text mining | PubMed |
| System Analysis Identifies MYBL2 As a Novel Oncogene Target for Metastatic Prostate Cancer. | J Cancer | 2025 | 40092688 | PubTator, text mining | PubMed |
| SnRK1 acts upstream of PRODUCTION OF ANTHOCYANIN PIGMENT1 during high light acclimation. | J Exp Bot | 2025 | 40063672 | PubTator, text mining | PubMed |
| CORR Insights®: CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections. | Clin Orthop Relat Res | 2025 | 40062883 | PubTator, text mining | PubMed |
| Replicative senescence in amniotic fluid-derived mesenchymal stem cells and its impact on their immunomodulatory properties. | Histochem Cell Biol | 2025 | 40042688 | PubTator, text mining | PubMed |
| CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis. | J Exp Clin Cancer Res | 2025 | 39980052 | PubTator, text mining | PubMed |
| CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections. | Clin Orthop Relat Res | 2025 | 39915095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4605/papers?page=6